LivaNova Plc is a global medical technology company that develops therapeutic solutions across three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. Their products include heart-lung machines, neuromodulation devices, and life support systems.
Francesco Bianchi sold 1,250 shares of LIVN on 11 December at $50.99 per share, worth a total of $64K. They now own 7,522 LIVN shares, or a 14% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
